Dermot S. McGlinchey Lifetime Achievement Award Presented to Gayle and Tom Benson
Mar 15, 2018 17:12 pm UTC| Business
NEW ORLEANS, March 15, 2018 -- McGlinchey Stafford will be recognized as part of the 2018 Tulane Alumni Awards with the presentation of the Dermot McGlinchey Lifetime Achievement Award. McGlinchey Stafford has been a...
Akers Biosciences Announces Conference Call to Discuss Fiscal Year 2017 Earnings
Mar 15, 2018 17:11 pm UTC| Business
THOROFARE, N.J, March 15, 2018 -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, will hold a conference call on Thursday, March...
Giggles N’ Hugs’ CEO Interview And Transcript With RedChip that aired on FOX Business Now Available
Mar 15, 2018 17:10 pm UTC| Business
Los Angeles, March 15, 2018 -- -- increasing sales, potential expansion, undervalued stock could mean opportunity for investors-- Malls see restaurant as a traffic-driving partner, not tenant -- Unique...
Mar 15, 2018 17:10 pm UTC| Business
ST. PETERSBURG, Fla., March 15, 2018 -- Leading entertainment and lifestyle retailer, HSN, is partnering with chef Michael and Liz Symon to launch Symon Home, their first-ever collection of cooking and entertaining...
Mountain America Credit Union Donates $15,000 to St. Luke’s Health Foundation
Mar 15, 2018 17:07 pm UTC| Business
BOISE, Idaho, March 15, 2018 -- As the preferred credit union of the Boise State Broncos, Mountain America Credit Union committed to donate $50 to a charity for every three-pointer completed by the Broncos men’s...
Southcross Energy Partners, L.P. Announces Availability of the 2017 K-1 Tax Package
Mar 15, 2018 17:00 pm UTC| Business
DALLAS, Texas, March 15, 2018 -- Southcross Energy Partners, L.P. (NYSE:SXE) (“Southcross”) today announced the availability of the 2017 tax packages for its unitholders, including Schedule K-1. The tax packages are...
Mar 15, 2018 17:00 pm UTC| Business
Phase 3 Trial received Approval to be Initiated in Israel Patient Accrual Already Resumed in the U.S. NANTES, France, March 15, 2018 -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE), today announces that the...